RxCelerate Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
100

- Latest Deal Type
-
Early Stage VC
- Investors
-
1
RxCelerate General Information
Description
Operator of an outsourced drug discovery and development platform intended to specialize in non-clinical models of diseases. The company's platform offers bespoke efficacy models, including a study design that combines efficacy and toxicology end-points in a single study wrapper and specializes in bespoke experimental design with data-rich endpoints, enabling researchers to improve the productivity of drug discovery and development.
Contact Information
Website
www.rxcelerate.comCorporate Office
- The Dorothy Hodgkin Building
- Babraham Research Campus, Babraham
- Cambridge CB22 3FH
- England, United Kingdom
Corporate Office
- The Dorothy Hodgkin Building
- Babraham Research Campus, Babraham
- Cambridge CB22 3FH
- England, United Kingdom
RxCelerate Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | 01-Jan-2015 | Completed | Generating Revenue |
RxCelerate Patents
RxCelerate Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202219662-D0 | Reagents for building to a binding site | Active | 23-Dec-2022 | ||
GB-2620811-A | Reagents for binding to a binding site | Active | 23-Dec-2022 | ||
GB-2620811-B | Reagents for binding to a binding site | Active | 23-Dec-2022 | G16C20/50 |
RxCelerate Signals
RxCelerate Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Total Medical Ventures | Venture Capital | Minority |
RxCelerate Investments & Acquisitions (6)
RxCelerate’s most recent deal was a Merger/Acquisition with Methuselah Health. The deal was made on 22-Nov-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Methuselah Health | 22-Nov-2022 | Merger/Acquisition | Biotechnology | ||
Rivus Pharmaceuticals | 19-Aug-2022 | Early Stage VC | Drug Discovery | ||
Rivus Pharmaceuticals | 20-Jul-2021 | Early Stage VC | Drug Discovery | ||
Prosarix | 05-Feb-2019 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
The Cambridge Partnership | 08-May-2018 | Merger/Acquisition | Other Commercial Services |
RxCelerate Affiliates
Subsidiaries (4)
Name | Industry | Location | Year Founded |
---|---|---|---|
RxBiologics | Cambridge, United Kingdom | 2017 | |
Methuselah Health | Cambridge, United Kingdom | 2015 | |
The Cambridge Partnership | Cambridge, United Kingdom | 2013 | |
Prosarix | Cambridge, United Kingdom | 2006 |
RxCelerate FAQs
-
When was RxCelerate founded?
RxCelerate was founded in 2012.
-
Where is RxCelerate headquartered?
RxCelerate is headquartered in Cambridge, United Kingdom.
-
What is the size of RxCelerate?
RxCelerate has 100 total employees.
-
What industry is RxCelerate in?
RxCelerate’s primary industry is Drug Discovery.
-
Is RxCelerate a private or public company?
RxCelerate is a Private company.
-
What is RxCelerate’s current revenue?
The current revenue for RxCelerate is
. -
Who are RxCelerate’s investors?
Total Medical Ventures has invested in RxCelerate.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »